Review of Genotoxic Impurities: Strategies for Identification and Control

被引：0
|
作者：
Theresa Allio
机构：
[1] The Weinberg Group,
来源：
Drug information journal : DIJ / Drug Information Association | 2012年 / 46卷 / 2期
关键词：
D O I：
10.1177/0092861512436582
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：235 / 236
页数：1
相关论文
共 50 条
  • [21] Identification, synthesis, and characterization of potential genotoxic impurities of sildenafil citrate drug substance
    P. Rajesh Reddy
    Sivanadh Musunuri
    D. Rama Sekhara Reddy
    V. Subrahmanyam Chittala
    V. N. S. Murthy P
    K. Krishnamohan
    [J]. Future Journal of Pharmaceutical Sciences, 6
  • [22] Genotoxic impurities: A quantitative approach
    Yuabova, Zhanna Y.
    Holschlag, David R.
    Rodriguez, Shirley A.
    Qin, Cindy
    Papov, Vladimir V.
    Qiu, Fenghe
    McCaffrey, John F.
    Norwood, Daniel L.
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY & RELATED TECHNOLOGIES, 2008, 31 (15) : 2318 - 2330
  • [23] Determination of Genotoxic Impurities in Pharmaceuticals
    David, Frank
    Alegre, Maria Rambla
    Vanhoenacker, Gerd
    Sandra, Pat
    [J]. LC GC EUROPE, 2013, : 31 - 34
  • [24] Identification, synthesis, and characterization of potential genotoxic impurities of sildenafil citrate drug substance
    Rajesh Reddy, P.
    Musunuri, Sivanadh
    Rama Sekhara Reddy, D.
    Chittala, V. Subrahmanyam
    Murthy, V. N. S. P.
    Krishnamohan, K.
    [J]. FUTURE JOURNAL OF PHARMACEUTICAL SCIENCES, 2020, 6 (01)
  • [25] Identification, synthesis, and control of efinaconazole impurities
    Zhu, Fuqiang
    Zhang, Jian
    Xiamuxi, Hainimu
    Chen, Weiming
    Hu, Tianwen
    Yang, Xiaojun
    Tian, Guanghui
    Ni, Runyan
    Li, Jian
    Suo, Jin
    Xie, Yuanchao
    Shen, Jingshan
    Aisa, Haji A.
    He, Yang
    [J]. PHARMAZIE, 2018, 73 (08): : 438 - 441
  • [26] ENVR 166-Control of genotoxic and carcinogenic impurities in an active pharmaceutical ingredient
    Shi, Yueer
    He, Brian
    Kubin, Michelle L.
    Fyfe, Helen
    Kleintop, Brent
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2009, 238
  • [27] Risk assessment and control of potentially genotoxic impurities: Implementation of a fully integrated approach
    Devastato, C.
    Fioravanzo, E.
    Kovarich, S.
    Pavan, M.
    Schwab, C.
    Ombrato, R.
    Corradin, M.
    Silvestri, L.
    Yang, C.
    [J]. TOXICOLOGY LETTERS, 2016, 258 : S203 - S204
  • [28] The assessment of impurities for genotoxic potential and subsequent control in drug substance and drug product
    Dow, Linda K.
    Hansen, Marvin M.
    Pack, Brian W.
    Page, Todd J.
    Baertschi, Steven W.
    [J]. JOURNAL OF PHARMACEUTICAL SCIENCES, 2013, 102 (05) : 1404 - 1418
  • [29] Overview of Genotoxic Impurities in Pharmaceutical Development
    Bercu, Joel P.
    Dobo, Krista L.
    Gocke, Elmar
    McGovern, Timothy J.
    [J]. INTERNATIONAL JOURNAL OF TOXICOLOGY, 2009, 28 (06) : 468 - 478
  • [30] Risk assessment of genotoxic impurities in pharmaceuticals
    Humfrey, Charles
    [J]. TOXICOLOGY LETTERS, 2009, 189 : S39 - S39
12345